Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28556
Title: Bone Microarchitecture in Transgender Adults: a Cross Sectional Study.
Austin Authors: Bretherton, Ingrid ;Ghasem-Zadeh, Ali ;Leemaqz, Shalem Y;Seeman, Ego ;Wang, Xiao-Fang ;McFarlane, Thomas;Spanos, Cassandra;Grossmann, Mathis ;Zajac, Jeffrey D ;Cheung, Ada S 
Affiliation: College of Medicine and Public Health, Flinders University, Australia
Dept of Medicine, The University of Melbourne, Australia
Endocrinology
Issue Date: 3-Jan-2022
metadata.dc.date: 2022-01-03
Publication information: Journal of Bone and Mineral Research 2022; online first: 3 January
Abstract: Gender-affirming hormone therapy aligns physical characteristics with an individual's gender identity, but sex hormones regulate bone remodelling and influence bone morphology. We hypothesised that trans men receiving testosterone have compromised bone morphology due to suppression of ovarian estradiol production while trans women receiving estradiol, with or without antiandrogen therapy, have preserved bone microarchitecture. We compared distal radial and tibial microarchitecture using high-resolution peripheral quantitative CT images in a cross-sectional study of 41 trans men with 71 cis female controls, and 40 trans women with 51 cis male controls. Between group differences were expressed as standardized deviations (SD) from the mean in age-matched cis gender controls with 98% confidence intervals adjusted for cross sectional area (CSA) and multiple comparisons. Relative to cis women, trans men had 0.63 SD higher total vBMD (both p = 0.01). Cortical vBMD and cortical porosity did not differ, but cortices were 1.11 SD thicker (p < 0.01). Trabeculae were 0.38 SD thicker (p = 0.05) but otherwise no different. Compared to cis men, trans women had 0.68 SD lower total vBMD (p = 0.01). Cortical vBMD was 0.70 SD lower (p < 0.01), cortical thickness was 0.51 SD lower (p = 0.04), cortical porosity was 0.70 SD higher (p<0.01). Trabecular BV/TV was 0.77 SD lower (p < 0.01), with 0.57 SD fewer (p < 0.01) and 0.30 SD thicker trabeculae (p = 0.02). There was 0.56 SD greater trabecular separation (p = 0.01). Findings at the distal radius were similar. Contrary to each hypothesis, bone microarchitecture was not compromised in trans men, perhaps because aromatisation of administered testosterone prevented bone loss. Trans women had deteriorated bone microarchitecture either because of deficits in microstructure before treatment, or because the estradiol dosage was insufficient to offset reduced aromatizable testosterone. Prospective studies are needed to confirm these findings. This article is protected by copyright. All rights reserved.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28556
DOI: 10.1002/jbmr.4497
ORCID: https://orcid.org/0000-0002-5284-9239
https://orcid.org/0000-0003-3246-3205
https://orcid.org/0000-0001-8261-3457
https://orcid.org/0000-0001-5257-5525
PubMed URL: 34981566
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/34981566/
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

4
checked on Jan 27, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.